This is a federal contract award from the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,064.40, is for the delivery of sodium chloride 0.9% injection, a common pharmaceutical product.
The contract is a firm fixed-price purchase order with an ultimate completion date of April 15, 2024. It is not associated with any set-aside designation.
DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The IDC complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites.
Generated 10/6/24, 9:05 AM